Stock Spotlight: Fisher & Paykel Healthcare (ASX:FPH)

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.



Key Stats

Source: Yahoo Finance. Data as of 19/08/25.

Price Performance

Growth Potential

  • Global leader in invasive and non-invasive inhalation, nasal high flow therapy and during surgery.
  • Strong global market position in a significantly under-penetrated treatment of sleep apnea market and chronic obstructive pulmonary disease.
  • Increasing uptake of Nasal high-flow (NHF) therapy and consumables growth on the back of this.
  • High barriers to entry in establishing global distribution channels.
  • Strong R&D program ensuring new product releases and FPH remains ahead of competitors.
  • Bolt-on acquisitions to supplement organic growth.


Key Risks

  • Consolidation / normalization of sales post the COVID-19 driven demand.
  • Disruptive technology leading to better patient compliance.
  • Product recall leading to reputational damage.
  • Competitive threats leading to market share loss.
  • Disappointing growth (company and industry specific).
  • Adverse currency movements.
  • FPH needs to grow to maintain its high PE trading multiple. Therefore, any impact on growth may put pressure on FPH’s valuation.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

CPI Explained: Why One Number Drives Markets, Rates and Portfolios

March 19, 2026
CPI moves markets, rates and portfolios every month. Understand how the transmission works and what investors should focus on beyond the headline number.

Gold Is Holding Near $5,000: Why the Fed Will Decide What Happens Next

March 18, 2026
Despite an escalating Middle East conflict, gold is stalling near $5,000. Find out why policy clarity, and not geopolitics, will determine the next big move.

RBA Hikes to 4.10%: Why the Latest Move Is Sending Mixed Signals Across Markets

March 18, 2026
The RBA raised the cash rate to 4.10% in in a divided 5–4 decision. We break down market reactions, policy signals and investment positioning implications.

The VIX in a Crisis: What the Market’s Fear Gauge Reveals

March 13, 2026
What does the VIX reveal during market turmoil? Learn how the market’s fear gauge measures volatility, investor sentiment, and what it means for investors.

ASX Loses $90bn as Iran Conflict Escalates — What It Means for Retirement Savings

March 12, 2026
As geopolitical tensions wiped $90bn from the ASX, investors are asking what it means for super. Here’s how market volatility can impact retirement savings.

Asia on the Brink as the Oil Shock Hits Hard

March 11, 2026
An escalating oil shock is testing Asia’s energy dependence, raising inflation risks, pressuring currencies and increasing volatility across global equity markets.

Playing the Long Game: Why Time in the Market Beats Timing the Market

March 6, 2026
Explore why time in the market consistently outperforms market timing and how disciplined, long-term investing helps build wealth through compounding.

Stock Spotlight: oOh!media Limited (ASX:OML)

March 5, 2026
This week's Stock Spotlight is ASX-listed oOh!media Limited. About oOh!media Limited. oOh!media Limited engages in the outdoor media, and production and advertising businesses in Australia and New Zealand. It offers large format digital and classic roadside screens; large and small format digital and classic signs located in retail precincts, such as shopping centres, airport terminals, lounges and in flight; digital and classic street furniture signs; digital and classic format advertising in public transport corridors, including rail; and digital and classic signs in high dwell time environments, such as universities and office buildings. The company also provides advertising creative and printing services. oOh!media Limited was founded in 1989 and is based in North Sydney, Australia. Source: EODHD Key Stats

Stock Spotlight: Goodman Group (ASX:GMG)

March 5, 2026
Get the latest news on Goodman Group (ASX:GMG), including stock performance, technical analysis, forecasts & key insights. See if GMG supports your goals.

The New Energy Paradox: Why the Gulf Crisis Is Supporting Both Oil and Renewables

March 5, 2026
Gulf tensions are accelerating oil investment and the energy transition. Analyse how the conflict is influencing oil markets, renewables and ASX opportunities.